Patent · US Active

Meningococcal and pneumococcal conjugate vaccine and method of using same

US8003112B2 · kind B2 · utility

0Cited by

4References

5Claims

0Family size

Assignees

Howard University · US
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · US

Inventors

Stanley Shih-Peng Tai · Rockville, US
Che-Hung Robert Lee · Silver Spring, US

Key dates

Filing date	Apr 16, 2009
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Apr 16, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S424/831
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to vaccine formulations comprising an immunogenic composition for inducing antibodies to both S. pneumoniae and N. meningitides in a subject. In a preferred aspect, the immunogenic composition comprises covalently conjugated recombinant PsaA (“rPsaA”) from S. pneumoniae and capsular polysaccharide from N. meningitidis serogroup C. This disclosure further relates to methods for producing the immunogenic composition as well as methods for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.